Lars Börnsen

1.7k total citations
32 papers, 1.3k citations indexed

About

Lars Börnsen is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology. According to data from OpenAlex, Lars Börnsen has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pathology and Forensic Medicine, 14 papers in Immunology and 7 papers in Oncology. Recurrent topics in Lars Börnsen's work include Multiple Sclerosis Research Studies (23 papers), Immunotherapy and Immune Responses (9 papers) and T-cell and B-cell Immunology (7 papers). Lars Börnsen is often cited by papers focused on Multiple Sclerosis Research Studies (23 papers), Immunotherapy and Immune Responses (9 papers) and T-cell and B-cell Immunology (7 papers). Lars Börnsen collaborates with scholars based in Denmark, Sweden and United States. Lars Börnsen's co-authors include Finn Sellebjerg, Per Soelberg Sørensen, Jeppe Romme Christensen, Tomas Olsson, Mohsen Khademi, Rikke Ratzer, Helle Bach Søndergaard, Martin Krakauer, Fredrik Piehl and Cecilie Ammitzbøll and has published in prestigious journals such as PLoS ONE, Neurology and Frontiers in Immunology.

In The Last Decade

Lars Börnsen

32 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Börnsen Denmark 18 752 487 270 265 250 32 1.3k
Yusei Miyazaki Japan 18 857 1.1× 840 1.7× 232 0.9× 414 1.6× 157 0.6× 65 1.6k
Lenka Novakova Sweden 17 1.1k 1.4× 323 0.7× 281 1.0× 496 1.9× 353 1.4× 45 1.5k
Marvin M. van Luijn Netherlands 18 434 0.6× 571 1.2× 223 0.8× 148 0.6× 202 0.8× 43 1.1k
Andreas Schulte‐Mecklenbeck Germany 19 435 0.6× 630 1.3× 270 1.0× 217 0.8× 177 0.7× 53 1.3k
Takaaki Ishizu Japan 15 733 1.0× 311 0.6× 277 1.0× 556 2.1× 146 0.6× 22 1.2k
Annet F. Wierenga‐Wolf Netherlands 21 475 0.6× 750 1.5× 287 1.1× 158 0.6× 181 0.7× 39 1.5k
C. Bash United States 17 890 1.2× 272 0.6× 179 0.7× 278 1.0× 267 1.1× 21 1.2k
Thomas Prod’homme United States 16 653 0.9× 1.1k 2.3× 463 1.7× 221 0.8× 302 1.2× 26 2.0k
Xiaonan Zhong China 20 602 0.8× 266 0.5× 221 0.8× 451 1.7× 88 0.4× 46 1.0k
Peter J. Darlington Canada 18 463 0.6× 753 1.5× 447 1.7× 146 0.6× 215 0.9× 35 1.6k

Countries citing papers authored by Lars Börnsen

Since Specialization
Citations

This map shows the geographic impact of Lars Börnsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Börnsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Börnsen more than expected).

Fields of papers citing papers by Lars Börnsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Börnsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Börnsen. The network helps show where Lars Börnsen may publish in the future.

Co-authorship network of co-authors of Lars Börnsen

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Börnsen. A scholar is included among the top collaborators of Lars Börnsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Börnsen. Lars Börnsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ammitzbøll, Cecilie, Tim B. Dyrby, Lars Börnsen, et al.. (2023). NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosis. Multiple Sclerosis and Related Disorders. 77. 104854–104854. 5 indexed citations
2.
Essen, Marina Rode von, Cecilie Ammitzbøll, Lars Börnsen, & Finn Sellebjerg. (2021). Assessment of commonly used methods to determine myelin-reactivity of T cells in multiple sclerosis. Clinical Immunology. 230. 108817–108817. 4 indexed citations
3.
Søndergaard, Helle Bach, et al.. (2021). Biomarkers of systemic inflammation, soluble IL-2Rα and the multiple sclerosis-associated IL2RA SNP rs2104286 in healthy subjects and multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 54. 103140–103140. 5 indexed citations
4.
Søndergaard, Helle Bach, Laura Airas, Jeppe Romme Christensen, et al.. (2021). Pregnancy-Induced Changes in microRNA Expression in Multiple Sclerosis. Frontiers in Immunology. 11. 552101–552101. 16 indexed citations
5.
Ammitzbøll, Cecilie, Lars Börnsen, Eva Rosa Petersen, et al.. (2019). Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation. Journal of Neuroimmunology. 330. 90–95. 12 indexed citations
6.
Petersen, Eva Rosa, Cecilie Ammitzbøll, Helle Bach Søndergaard, et al.. (2019). Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosis. Journal of Neuroimmunology. 337. 577085–577085. 8 indexed citations
7.
Ammitzbøll, Cecilie, Marina Rode von Essen, Lars Börnsen, et al.. (2018). GPR15+ T cells are Th17 like, increased in smokers and associated with multiple sclerosis. Journal of Autoimmunity. 97. 114–121. 25 indexed citations
8.
Christensen, Jeppe Romme, Mika Komori, Marina Rode von Essen, et al.. (2018). CSF inflammatory biomarkers responsive to treatment in progressive multiple sclerosis capture residual inflammation associated with axonal damage. Multiple Sclerosis Journal. 25(7). 937–946. 32 indexed citations
9.
Nielsen, Birgitte, Rikke Ratzer, Lars Börnsen, et al.. (2017). Characterization of naïve, memory and effector T cells in progressive multiple sclerosis. Journal of Neuroimmunology. 310. 17–25. 25 indexed citations
10.
Ratzer, Rikke, et al.. (2017). Relationship between soluble CD25 and gene expression in healthy individuals and patients with multiple sclerosis. Cytokine. 93. 15–25. 12 indexed citations
11.
Nielsen, Claus Henrik, Lars Börnsen, Finn Sellebjerg, & Marie K. Brimnes. (2016). Myelin Basic Protein-Induced Production of Tumor Necrosis Factor-α and Interleukin-6, and Presentation of the Immunodominant Peptide MBP85-99 by B Cells from Patients with Relapsing-Remitting Multiple Sclerosis. PLoS ONE. 11(1). e0146971–e0146971. 7 indexed citations
12.
Søndergaard, Helle Bach, et al.. (2015). Identification of Suitable Reference Genes for Peripheral Blood Mononuclear Cell Subset Studies in Multiple Sclerosis. Scandinavian Journal of Immunology. 83(1). 72–80. 36 indexed citations
13.
Ratzer, Rikke, Pernille Iversen, Lars Börnsen, et al.. (2015). Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis. Multiple Sclerosis Journal. 22(7). 926–934. 25 indexed citations
14.
Börnsen, Lars, Jeppe Romme Christensen, Rikke Ratzer, et al.. (2015). Endogenous Interferon-β-Inducible Gene Expression and Interferon-β-Treatment Are Associated with Reduced T Cell Responses to Myelin Basic Protein in Multiple Sclerosis. PLoS ONE. 10(3). e0118830–e0118830. 17 indexed citations
15.
Ratzer, Rikke, Jeppe Romme Christensen, Birgitte Nielsen, et al.. (2014). Immunological effects of methylprednisolone pulse treatment in progressive multiple sclerosis. Journal of Neuroimmunology. 276(1-2). 195–201. 10 indexed citations
16.
Christensen, Jeppe Romme, Lars Börnsen, Rikke Ratzer, et al.. (2013). Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression. PLoS ONE. 8(3). e57820–e57820. 199 indexed citations
17.
Börnsen, Lars, Jeppe Romme Christensen, Rikke Ratzer, et al.. (2012). Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis. PLoS ONE. 7(11). e47578–e47578. 46 indexed citations
18.
Christensen, Jeppe Romme, Lars Börnsen, Dan Hesse, et al.. (2012). Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis. Journal of Neuroinflammation. 9(1). 215–215. 68 indexed citations
19.
Søndergaard, Helle Bach, Finn Sellebjerg, Jan Hillert, et al.. (2011). Alterations in KLRB1 gene expression and a Scandinavian multiple sclerosis association study of the KLRB1 SNP rs4763655. European Journal of Human Genetics. 19(10). 1100–1103. 9 indexed citations
20.
Khademi, Mohsen, Lars Börnsen, Magnus Andersson, et al.. (2009). The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment‐sensitive biomarkers. European Journal of Neurology. 16(4). 528–536. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yusei Miyazaki Breakdown of academic impact, for papers by Lenka Novakova Breakdown of academic impact, for papers by Marvin M. van Luijn Breakdown of academic impact, for papers by Andreas Schulte‐Mecklenbeck Breakdown of academic impact, for papers by Takaaki Ishizu Breakdown of academic impact, for papers by Annet F. Wierenga‐Wolf Breakdown of academic impact, for papers by C. Bash Breakdown of academic impact, for papers by Thomas Prod’homme Breakdown of academic impact, for papers by Xiaonan Zhong Breakdown of academic impact, for papers by Peter J. Darlington
Rankless by CCL
2026